Lost cases. by Nan Tang (642590)

“…</p><p>Results</p><p>The intervention group showed a significant decrease in anxiety (t =  11.906, P <  0.001) and depression scores (t =  14.991, P <  0.001), as well as PSQI scores (t =  7.055, P <  0.001), and increased FertiQoL scores (t =  -2.828, P <  0.001). …”

Group control-before intervention. by Nan Tang (642590)

“…</p><p>Results</p><p>The intervention group showed a significant decrease in anxiety (t =  11.906, P <  0.001) and depression scores (t =  14.991, P <  0.001), as well as PSQI scores (t =  7.055, P <  0.001), and increased FertiQoL scores (t =  -2.828, P <  0.001). …”

Patient satisfaction with SFA intervention(%). by Nan Tang (642590)

“…</p><p>Results</p><p>The intervention group showed a significant decrease in anxiety (t =  11.906, P <  0.001) and depression scores (t =  14.991, P <  0.001), as well as PSQI scores (t =  7.055, P <  0.001), and increased FertiQoL scores (t =  -2.828, P <  0.001). …”

Pre-Experiment. by Nan Tang (642590)

“…</p><p>Results</p><p>The intervention group showed a significant decrease in anxiety (t =  11.906, P <  0.001) and depression scores (t =  14.991, P <  0.001), as well as PSQI scores (t =  7.055, P <  0.001), and increased FertiQoL scores (t =  -2.828, P <  0.001). …”

Group SFA-after intervention. by Nan Tang (642590)

“…</p><p>Results</p><p>The intervention group showed a significant decrease in anxiety (t =  11.906, P <  0.001) and depression scores (t =  14.991, P <  0.001), as well as PSQI scores (t =  7.055, P <  0.001), and increased FertiQoL scores (t =  -2.828, P <  0.001). …”

Bidimensional Low-High Frequency Normalized Difference and High-Low Frequency Power (LHFND, LHFP) plane representation of the interaction among Phase and High-Low Authoritativeness... by David Vagni (8060432)

Age-specific numbers and rates of DALYs (A) and deaths (B) for <i><i>Klebsiella pneumoniae</i></i> associated LRI burden by sex, 2021. DALYs disability-adjusted life years. by Juanjuan Li (399633)

Subjects:

The trends in numbers of DALYs and deaths for <i><i>Klebsiella pneumoniae</i></i> associated LRI burden from 1990 to 2021. DALYs, disability-adjusted life years. by Juanjuan Li (399633)

Subjects:

Deaths rate and SDI across all regions between 1990 and 2021 (a). Deaths rate across all countries in 2021 by SDI (b). SDI socio-demographic index. by Juanjuan Li (399633)

Subjects:

The global disease burden of <i><i>Klebsiella pneumoniae</i></i> associated LRI for both sexes in 204 countries and territories. (a) The number of DALYs in 2021; (b) The EAPC of DA... by Juanjuan Li (399633)

Subjects:

DALYs rate and SDI across all regions between1990 and 2021 (a). DALYs rate across all countries in 2021 by SDI (b). DALYs disability-adjusted life years, SDI socio-demographic inde... by Juanjuan Li (399633)

Subjects:

The number and ASR of deaths for <i>Klebsiella pneumoniae</i>-related LRI burden in 1990 and 2021, and its trends from 1990 to 2021. by Juanjuan Li (399633)

Subjects:

The number and ASR of DALYs for <i>Klebsiella pneumoniae</i>-related LRI burden in 1990 and 2021, and its trends from 1990 to 2021. by Juanjuan Li (399633)

Subjects:

Conceptual framework to guide the study. by Resham B. Khatri (10949429)

Subjects:

Correlation between relative amounts of lipid species and number of days since the onset of symptoms among COVID-19 cases. by Spela Kokelj (8356644)

Subjects:

Correlation between protein abundances and R_5-20 z-score among cases at baseline. Protein abundances, normalized to mean 0 and variance 1, are displayed on the y-axis. (... by Spela Kokelj (8356644)

Subjects:

General characteristics and clinical data of the subjects included in the study. by Spela Kokelj (8356644)

Subjects:

Distribution of average relative amounts of lipid classes. by Spela Kokelj (8356644)

Subjects:

Flow chart on the inclusion and drop out of patients. by Spela Kokelj (8356644)

Subjects:

Differentially abundant lipid species in COVID-19 cases at baseline and at follow-up as compared to healthy controls. by Spela Kokelj (8356644)

Subjects: